http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2016256668-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a140eb40d1e7437d8b8ea7e32eb9785d |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| filingDate | 2016-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_88479b2121eecb782974065e24682382 |
| publicationDate | 2016-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AU-2016256668-A1 |
| titleOfInvention | Prevention and treatment of amyloidogenic disease |
| abstract | PREVENTION AND TREATMENT OF AMYLOIDOGENIC Abstract The invention provides compositions and methods for treatment of amyloidogenic diseases. Such methods entail administering an agent that induces a beneficial immune response against an amyloid deposit in the patient. The methods are particularly useful for prophylactic and therapeutic treatment of Alzheimer's disease. In such methods, a suitable agent is Apl peptide or an antibody thereto. |
| priorityDate | 1997-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 282.